Identification of epistatic interactions through genome-wide association studies in sporadic medullary and juvenile papillary thyroid carcinomas

[1]  E. Kim,et al.  Thyroid Cancer: A Comprehensive Guide to Clinical Management , 2017, The Journal of Nuclear Medicine.

[2]  Amanda C. Schierz,et al.  canSAR: an updated cancer research and drug discovery knowledgebase , 2015, Nucleic Acids Res..

[3]  Rosa D. Hernansaiz-Ballesteros,et al.  Babelomics 5.0: functional interpretation for new generations of genomic data , 2015, Nucleic Acids Res..

[4]  G. von Heijne,et al.  Tissue-based map of the human proteome , 2015, Science.

[5]  Ying Zhang,et al.  The neXtProt knowledgebase on human proteins: current status , 2014, Nucleic Acids Res..

[6]  Huiling He,et al.  Genetic predisposition to papillary thyroid carcinoma: involvement of FOXE1, TSHR, and a novel lincRNA gene, PTCSC2. , 2015, The Journal of clinical endocrinology and metabolism.

[7]  Yan Zhao,et al.  BRAF-activated long non-coding RNA contributes to cell proliferation and activates autophagy in papillary thyroid carcinoma , 2014, Oncology letters.

[8]  Jason H. Moore,et al.  Why epistasis is important for tackling complex human disease genetics , 2014, Genome Medicine.

[9]  Wei Wu,et al.  NONCODEv4: exploring the world of long non-coding RNA genes , 2013, Nucleic Acids Res..

[10]  J. Herman,et al.  Emerging evidence for CHFR as a cancer biomarker: from tumor biology to precision medicine , 2013, Cancer and Metastasis Reviews.

[11]  A. Chakravarti,et al.  Pathways systematically associated to Hirschsprung’s disease , 2013, Orphanet Journal of Rare Diseases.

[12]  Sean R. Davis,et al.  NCBI GEO: archive for functional genomics data sets—update , 2012, Nucleic Acids Res..

[13]  K. Schmid,et al.  Clinical and pathologic features of "sporadic" papillary thyroid carcinoma registered in the years 2005 to 2008 in children and adolescents of Belarus. , 2012, Thyroid : official journal of the American Thyroid Association.

[14]  Cristina Y. González,et al.  Multicore and Cloud-Based Solutions for Genomic Variant Analysis , 2012, Euro-Par Workshops.

[15]  K. Schmid,et al.  Clinical and pathologic features of 'sporadic' papillary thyroid carcinoma registered in 2005-2008 years in children and adolescents of Belarus. , 2012 .

[16]  Marta Bleda,et al.  CellBase, a comprehensive collection of RESTful web services for retrieving relevant biological information from heterogeneous sources , 2012, Nucleic Acids Res..

[17]  G. Sassolas,et al.  Oncogenic alterations in papillary thyroid cancers of young patients. , 2012, Thyroid : official journal of the American Thyroid Association.

[18]  Tsippi Iny Stein,et al.  In-silico human genomics with GeneCards , 2011, Human Genomics.

[19]  Mercedes Robledo,et al.  Association studies in thyroid cancer susceptibility: are we on the right track? , 2011, Journal of molecular endocrinology.

[20]  Randal S. Weber,et al.  CpG island methylation profiling in human salivary gland adenoid cystic carcinoma , 2011, Cancer.

[21]  A. Berrington de González,et al.  Medical exposure to radiation and thyroid cancer. , 2011, Clinical oncology (Royal College of Radiologists (Great Britain)).

[22]  V. Topkara,et al.  An Introduction to Small Non-coding RNAs: miRNA and snoRNA , 2011, Cardiovascular Drugs and Therapy.

[23]  Andrew P Morris,et al.  Basic statistical analysis in genetic case-control studies , 2011, Nature Protocols.

[24]  Mingming Jia,et al.  COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer , 2010, Nucleic Acids Res..

[25]  Gary D. Bader,et al.  The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function , 2010, Nucleic Acids Res..

[26]  K. Schmid,et al.  Multiple endocrine neoplasia type 2. , 2010, Best practice & research. Clinical endocrinology & metabolism.

[27]  F. Collins,et al.  Potential etiologic and functional implications of genome-wide association loci for human diseases and traits , 2009, Proceedings of the National Academy of Sciences.

[28]  F. Collins,et al.  The HapMap and genome-wide association studies in diagnosis and therapy. , 2009, Annual review of medicine.

[29]  M. Zou,et al.  Oncogenic activation of MAP kinase by BRAF pseudogene in thyroid tumors. , 2009, Neoplasia.

[30]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[31]  Joaquín Dopazo,et al.  Association study of 69 genes in the ret pathway identifies low-penetrance loci in sporadic medullary thyroid carcinoma. , 2007, Cancer research.

[32]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[33]  D. Allison,et al.  Detection of gene x gene interactions in genome-wide association studies of human population data. , 2007, Human heredity.

[34]  M. Brandi,et al.  Multiple endocrine neoplasia type 2 , 2006, Orphanet journal of rare diseases.

[35]  D. Reich,et al.  Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.

[36]  S. Borrego,et al.  Analysis of RET polymorphisms and haplotypes in the context of sporadic medullary thyroid carcinoma. , 2006, Thyroid : official journal of the American Thyroid Association.

[37]  S. Asa,et al.  Pathogenetic mechanisms in thyroid follicular-cell neoplasia , 2006, Nature Reviews Cancer.

[38]  P. Vigneri,et al.  HMGA1 inhibits the function of p53 family members in thyroid cancer cells. , 2006, Cancer research.

[39]  J. Figge.  Epidemiology of Thyroid Cancer , 2006 .

[40]  S. Gabriel,et al.  Efficiency and power in genetic association studies , 2005, Nature Genetics.

[41]  J. Sandbank,et al.  Differentiated Thyroid Carcinoma in Children and Young Adults: Evaluation of Response to Treatment , 2005, Clinical nuclear medicine.

[42]  Liliane A. T. Arnaldi,et al.  Gene expression profiles reveal that DCN, DIO1, and DIO2 are underexpressed in benign and malignant thyroid tumors. , 2005, Thyroid : official journal of the American Thyroid Association.

[43]  Y. Benjamini,et al.  Controlling the false discovery rate in behavior genetics research , 2001, Behavioural Brain Research.

[44]  J. H. Moore,et al.  Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. , 2001, American journal of human genetics.

[45]  W. Hwu,et al.  Cloning of dimethylglycine dehydrogenase and a new human inborn error of metabolism, dimethylglycine dehydrogenase deficiency. , 2001, American journal of human genetics.

[46]  De Jong SA.  Thyroid cancer: A comprehensive guide to clinical management , 2000, Archives of pathology & laboratory medicine.

[47]  G. Sterrett,et al.  Medullary carcinoma of the thyroid , 1998 .

[48]  M. Dottorini,et al.  Differentiated thyroid carcinoma in children and adolescents: a 37-year experience in 85 patients. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[49]  C Eng,et al.  The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. , 1996, JAMA.